DOSE FINDING STUDY TO ASSESS SAFETY, PK AND EFFICACY OF FIMEPINOSTAT (CUDC‐907) WITH VENETOCLAX OR RITUXIMAB PLUS BENDAMUSTINE IN PATIENTS WITH RELAPSED/REFRACTORY LYMPHOMA. (12th June 2019) - Younes, A.; Batlevi, C.L.; Cohen, J.B.; Kelly, K.; Landsburg, D.J.; Patel, K.; Phillips, T.; Smith, S.; Westin, J.; Ma, A.W.; Grayson, D.; Barta, S.